are glp 1 still available Compounded GLP-1s: Why doctors worry and the FDA is cracking down Patients struggle as compounded GLP-1

10.1016/S0140-6736(02)07952-7 18

--- Here are some potential actions covered in the article for payers and employers to take as a result of this shift: Update formulary tiers and step therapy policies (consider the impact on comorbidities) Support members transitioning off GLP-1s after reaching their goals Create differentiated access pathways based on patient risk profiles Monitor realworld outcomes beyond A1C (cardiovascular, renal, adherence) Model the downstream impact on generics and legacy therapies --- Commercial plans are accelerating GLP-1 uptake and favoring the simplicity of a single therapy

GLP-1 medications support losing weight, but they can also be life-changing for physical and emotional well-being

Read more about GLP-1 supplements and whether they actually work